Transgene Biotek Ltd.
BSE: 526139 | Sector: Health care |
NSE: N.A. | ISIN Code: INE773D01018 |
BSE 00:00 | 17 Aug | 3.38 |
-0.02 (-0.59%) |
OPEN
3.57 |
HIGH
3.57 |
LOW
3.23 |
NSE 05:30 | 01 Jan | Transgene Biotek Ltd |
OPEN | 3.57 |
PREVIOUS CLOSE | 3.40 |
VOLUME | 23837 |
52-Week high | 4.88 |
52-Week low | 3.02 |
P/E | |
Mkt Cap.(Rs cr) | 26 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Transgene Biotek Ltd. (TRANSGENEBIOTEK) - Half Yearly Result
Particulars (![]() |
Mar '22 | Sep '21 | Mar '21 | Sep '20 | Mar '20 |
Net Sales/Income From Operations | 0.09 | 0.00 | 0.17 | 0.00 | 0.00 |
Other Income | 0.12 | 0.09 | 0.18 | 0.09 | 0.08 |
Total Income | 0.21 | 0.09 | 0.35 | 0.09 | 0.09 |
Total Expenditure | 0.30 | 0.25 | 0.38 | 0.32 | 0.44 |
Operating Profit | -0.09 | -0.16 | -0.03 | -0.23 | -0.35 |
Interest | 0.11 | 0.11 | 0.13 | 0.13 | 0.15 |
Gross Profit | -0.20 | -0.27 | -0.16 | -0.36 | -0.50 |
Depreciation | 4.98 | 4.94 | 4.96 | 4.95 | 4.95 |
PBT | -5.19 | -5.21 | -5.12 | -5.31 | -5.45 |
Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit/(Loss) | -5.19 | -5.21 | -5.12 | -5.31 | -5.45 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | -5.19 | -5.21 | -5.12 | -5.31 | -5.45 |
Equity Share Capital | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | 0.00 | -0.69 | 0.00 | -0.70 | 0.00 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Transgene Biotek:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices